tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IMCR Stock Latest News

Immunocore Sets 2026 Strategic Priorities for Melanoma Growth
Company AnnouncementsImmunocore Sets 2026 Strategic Priorities for Melanoma Growth
2d ago
8K
IMCR
Immunocore announces 2026 strategic priorities
PremiumThe Fly
Immunocore announces 2026 strategic priorities
2d ago
IMCR
Immunocore price target raised to $40 from $36 at Morgan Stanley
PremiumThe Fly
Immunocore price target raised to $40 from $36 at Morgan Stanley
3d ago
IMCR
Immunocore upgraded to Buy from Sell at UBS
PremiumThe Fly
Immunocore upgraded to Buy from Sell at UBS
4d ago
IMCR
Immunocore Holdings Board Member Ranjeev Krishana Resigns
PremiumCompany Announcements
Immunocore Holdings Board Member Ranjeev Krishana Resigns
1M ago
8K
IMCR
Immunocore’s Strong Growth Potential Justifies Buy Rating Despite Minor Revenue Adjustment
PremiumRatingsImmunocore’s Strong Growth Potential Justifies Buy Rating Despite Minor Revenue Adjustment
2M ago
IMCR
Immunocore price target raised to $36 from $34 at Morgan Stanley
Premium
The Fly
Immunocore price target raised to $36 from $34 at Morgan Stanley
2M ago
IMCR
Immunocore price target raised to $37 from $36 at Mizuho
Premium
The Fly
Immunocore price target raised to $37 from $36 at Mizuho
2M ago
IMCR
Immunocore Holdings: Strong Q3 Performance and Strategic Advancements Justify Buy Rating
PremiumRatings
Immunocore Holdings: Strong Q3 Performance and Strategic Advancements Justify Buy Rating
2M ago
IMCR
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD
PremiumThe Fly
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD
2M ago
IMCR
Immunocore Reports Strong Growth in Q3 2025
PremiumCompany Announcements
Immunocore Reports Strong Growth in Q3 2025
2M ago
IMCR
Immunocore reports Q3 EPS 0c, consensus (24c)
PremiumThe Fly
Immunocore reports Q3 EPS 0c, consensus (24c)
2M ago
IMCR
Apple upgraded, Comcast downgraded: Wall Street’s top analyst calls
PremiumThe FlyApple upgraded, Comcast downgraded: Wall Street’s top analyst calls
2M ago
U
APP
Immunocore initiated with an Overweight at Wells Fargo
Premium
The Fly
Immunocore initiated with an Overweight at Wells Fargo
2M ago
IMCR
Immunocore’s Innovative Approach: A New Hope for PRAME-Positive Cancer Treatment
Premium
Company Announcements
Immunocore’s Innovative Approach: A New Hope for PRAME-Positive Cancer Treatment
3M ago
IMCR
Immunocore’s Phase 3 Melanoma Study: A Potential Game Changer?
PremiumCompany Announcements
Immunocore’s Phase 3 Melanoma Study: A Potential Game Changer?
3M ago
IMCR
Immunocore’s Promising Melanoma Study: A Potential Game-Changer
PremiumCompany Announcements
Immunocore’s Promising Melanoma Study: A Potential Game-Changer
3M ago
IMCR
Immunocore’s Brenetafusp: A Promising Study in PRAME-Positive Cancers
PremiumCompany Announcements
Immunocore’s Brenetafusp: A Promising Study in PRAME-Positive Cancers
3M ago
IMCR
Immunocore’s Innovative Cancer Study: A Potential Game-Changer for Investors
PremiumCompany Announcements
Immunocore’s Innovative Cancer Study: A Potential Game-Changer for Investors
3M ago
IMCR
Immunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
PremiumRatingsImmunocore Holdings: Buy Rating Backed by Promising Clinical Data and Strategic Positioning
3M ago
IMCR
Immunocore assumed with a Neutral at Guggenheim
Premium
The Fly
Immunocore assumed with a Neutral at Guggenheim
4M ago
IMCR
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
Premium
Company Announcements
Immunocore’s Earnings Call Highlights Robust Growth and Strategic Expansion
5M ago
IMCR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >